Abstract:BACKGROUND:Lung cancer is the leading cause of malignant tumor death among Chinese population. It has been known that the development of lung cancer may be associated with genetic po-lymorphism of some lung cancer related genes. The aim of this study is to evaluate the relationship between genetic polymorphism of metabolizing enzymes and susceptibility of lung cancer in Chinese population.METHODS:Polymorphism of CYP2E1 RsaI/PstI and GSTM1 was detected in 99 patients with lung cancer and 66 patients with benign pulmonary disease by PCR-RFLP and PCR. The association between genetic polymorphism and susceptibility of lung cancer was analyzed.RESULTS:No significant difference in three RsaI/PstI genotype distribution of CYP2E1 was found between lung cancer group and control group (Chi-Square=1.374, P=0.241). (2) The frequency of GSTM1-null genotype in lung cancer group was significantly higher than that in control group (57.6% vs 40.9%, Chi-Square=4.401, P=0.036). (3) The individuals who carried with GSTM1-null genotype had a 1.96 fold increased risk of lung cancer (OR=1.96, 95%CI=1.042-3.689, P=0.037) than those who carried with GSTM1-present genotype. (4) When data were stratified by smoking status, the smokers who carried with c1/c1 genotype had a significantly higher risk of lung cancer (OR=3.525, 95%CI=1.168- 10.638, P=0.025) than those never-smokers who carried with at least one c2 allel. (5) When combination of polymorphism of CYP2E1 RsaI/PstI genotype and GSTM1 genotype was analyzed, compared with individuals who had concurrent present of GSTM1 and at least one c2 allel genotype, the risk of lung cancer for combination of GSTM1 null and c1/c1 genotype was increased significantly (OR=3.449, 95%CI=1.001- 11.886, P=0.050). Considering smoking status, compared with never-smokers who had concurrent present of GSTM1 and at least one c2 allel genotype, the risk of lung cancer for combination of GSTM1 null and c1/c1 genotype was remarkably increased (OR=11.553, 95%CI=1.068-124.944, P=0.044), as well as that for combination of GSTM1 null and at least one c2 allel genotype (OR=13.374, 95%CI=1.258-142.166, P= 0.032).CONCLUSIONS:(1)GSTM1 null genotype is an important factor associated with increased risk of lung cancer. (2) The combination of c1/c1 and GSTM1-null genotype can remarkably increase risk of lung cancer both in smokers and non-smokers.

A New Tumor-Related Gene-CYP2C19

Frequencies of Poor Metabolizers of Cytochrome P450 2C19 in Esophagus Cancer, Stomach Cancer, Lung Cancer and Bladder Cancer in Chinese Population

CYP2E1 T7632A and 9-Bp Insertion Polymorphisms and Colorectal Cancer Risk: a Meta-Analysis Based on 4,592 Cases and 5,918 Controls

[Association Between Genetic Polymorphisms of Metabolic Enzymes and Susceptibility of Colorectal Cancer].

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

Differences in cytochrome P450 2C19 (CYP2C19) expression in adjacent normal and tumor tissues in Chinese cancer patients.

Differences in cytochrome P4502C19 (CYP2C19) expression in adjacent normal and tumor tissues in chinese cancer patients

Association between missense mutations of CYP2A13 gene and lung cancer susceptibility

Sheng-Qiong Deng1&*, Xian-Tao Zeng2&,

Identification And Functional Characterization Of New Potentially Defective Alleles Of Human Cyp2c19

Association of CYP2C19*3 Gene Polymorphism with Breast Cancer in Chinese Women.

Meta-analysis of the CYP 1 A 2-163 C > A Polymorphism and Lung Cancer Risk

Functional Polymorphisms in the Cyp2c19 Gene Contribute to Digestive System Cancer Risk: Evidence from 11,042 Subjects

Study on Tissue Distribution Difference of Cytochrome P450 2C19 in Chinese Population Han

Association of CYP19A1 Polymorphism with Genetic Susceptibility to Lung Cancer in Chinese population:a case-control study

Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility.

Variants in CYP2J2 and CYP2C9 Contribute to Susceptibility of Lung Cancer

Genetic Polymorphisms of the CYP 19 A 1 Gene and Breast Cancer Survival

Polymorphisms Of Cyp, Gst And Xrcc1 And Risk Of Lung Cancer In A Chinese Population

HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers

[Study on the Association Between Genetic Polymorphism of CYP2E1, GSTM1 and Susceptibility of Lung Cancer].